.png?width=1248&height=564&name=Group%202%20(9).png)
Boosting the Potential of circRNA with MGB's Gene and Cell Therapy Institute
.png?width=1248&height=564&name=Group%202%20(9).png)

.png?width=2000&height=1052&name=Webinar%20social%20card%20abbvie%20%26%20promega%20(5).png)
Upcoming Webinar
Boosting the Potential of circRNA: Portal and MGB GCTI
Circular RNA is opening new doors for cell engineering from longer-lasting protein expression to multiplexed cargo delivery. Join researchers from MGB's Gene Therapy & Cell Innovation center and Portal Bio for a look at what makes circRNA exciting and what we're seeing as this technology moves from bench to application.
Even if you can't attend live, register anyway and we'll send you the recording afterwards!
Sign Up Here:
What You'll Learn:
- Why circular RNA: what makes it distinct from linear mRNA and where the field is heading
- Benefits of delivering multiple circRNA constructs to immune cells in a single step
- Uses of circRNA in stem cells and other hard-to-transfect cell types
- How multiplexed circRNA delivery enables co-expression of multiple proteins with sustained duration
- Early results: what the data is showing for cell therapy and engineering applications

.png?width=679&height=661&name=Group%202%20(10).png)
Armon Sharei
Founder & CEO Portal Bio

Alex Wesselhoeft
Director of RNA Therapeutics Core, Gene and Cell Therapy Institute